BRPI0612164A2 - composição para aplicação tópica e uso de uma composição - Google Patents

composição para aplicação tópica e uso de uma composição Download PDF

Info

Publication number
BRPI0612164A2
BRPI0612164A2 BRPI0612164-0A BRPI0612164A BRPI0612164A2 BR PI0612164 A2 BRPI0612164 A2 BR PI0612164A2 BR PI0612164 A BRPI0612164 A BR PI0612164A BR PI0612164 A2 BRPI0612164 A2 BR PI0612164A2
Authority
BR
Brazil
Prior art keywords
composition
topical application
oligosaccharide
mono
present
Prior art date
Application number
BRPI0612164-0A
Other languages
English (en)
Inventor
Hugues Gatto
Original Assignee
Virbac Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Sa filed Critical Virbac Sa
Publication of BRPI0612164A2 publication Critical patent/BRPI0612164A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIçãO PARA APLICAçãO TOPICA E USO DE UMA COMPOSIçãO. A presente invenção se refere a uma composição para a aplicação tópica, bem como ao uso dessa composição. A presente invenção se caracteriza pelo fato de compreender pelo menos um primeiro e um segundo mono- ou oligossacarídeo, sendo que cada um dos referidos primeiro e segundo mono- ou oligossacarídeo é capaz de limitar a aderência de microorganismos na pele de animais de sangue quente com pelagem.
BRPI0612164-0A 2005-04-04 2006-04-04 composição para aplicação tópica e uso de uma composição BRPI0612164A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503291A FR2883750B1 (fr) 2005-04-04 2005-04-04 Compositions topiques et leurs utilisations
PCT/FR2006/000730 WO2006106220A2 (fr) 2005-04-04 2006-04-04 Compositions topiques comprenant plusieurs mono-et/ou oligosaccharides pour le traitement des maladies cutanees d ' animaux a sang chaud a pelage

Publications (1)

Publication Number Publication Date
BRPI0612164A2 true BRPI0612164A2 (pt) 2010-10-19

Family

ID=35431411

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612164-0A BRPI0612164A2 (pt) 2005-04-04 2006-04-04 composição para aplicação tópica e uso de uma composição

Country Status (7)

Country Link
US (3) US20080200427A1 (pt)
EP (1) EP1868618A2 (pt)
JP (1) JP5107229B2 (pt)
AU (1) AU2006231248B2 (pt)
BR (1) BRPI0612164A2 (pt)
FR (1) FR2883750B1 (pt)
WO (1) WO2006106220A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5737646B2 (ja) * 2010-03-24 2015-06-17 森下仁丹株式会社 抗アレルギー剤
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis
FR2989274B1 (fr) * 2012-04-12 2016-02-26 Biochimie Appliquee Soc Composition cosmetique cutanee et/ou dermatologique destinee a limiter l'adhesion des bacteries pathogenes au niveau de la peau
PT3658160T (pt) 2017-07-28 2021-08-26 Isdin Sa Utilização de ramnose e seus derivados como agentes antifúngicos
WO2020229446A1 (en) * 2019-05-16 2020-11-19 Unilever N.V. Use of a sugar or sugar alcohol
DE102020133860A1 (de) 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB208690A (en) * 1922-12-21 1924-12-15 Pharmacia Ab Pharmaceutical preparation and a method for producing the same
US4518517A (en) * 1983-03-16 1985-05-21 Colgate-Palmolive Company Non-antimicrobial deodorant cleansing composition
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
FR2609397B1 (fr) * 1988-02-23 1991-12-13 Serobiologiques Lab Sa Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
FR2649888B1 (fr) * 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US6087320A (en) * 1989-09-14 2000-07-11 Henkel Corp. Viscosity-adjusted surfactant concentrate compositions
IL104399A0 (en) * 1992-01-22 1993-05-13 Mennen Co Deodorant compositions containing materials for inhibiting bacterial adherence,method of use thereof,and method for determining materials that inhibit bacterial adherence
SE9200199L (sv) * 1992-01-24 1993-07-25 Rune Soeremark Farmaceutisk komposition och dess anvaendning
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
US6777003B1 (en) * 1995-06-07 2004-08-17 Cognis Corporation Iodine complex of alkyl polyglycosides
US6057274A (en) * 1997-08-22 2000-05-02 Henkel Corporation Antibacterial composition having enhanced tactile properties
CA2245254A1 (en) * 1998-09-02 2000-03-02 Soheyl Mottahedeh Glycoside shampoo for treating psoriasis
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
US6767508B1 (en) * 2000-11-28 2004-07-27 Kimberly-Clark Worldwide, Inc. Nonwovens modified with alkyl polyglycoside surfactants
FR2820038B1 (fr) * 2001-01-29 2004-07-02 Dermaconcept Jmc Composition dermatologique a usage veterinaire comprenant une base sphingoide
DE10163246A1 (de) * 2001-12-21 2003-07-10 Henkel Kgaa Neue Verwendung von Apfelkernextrakten in kosmetischen oder pharmazeutischen Zusammensetzung
JP4509517B2 (ja) * 2002-09-19 2010-07-21 ロート製薬株式会社 黄色ブドウ球菌の皮膚付着を阻害し、かつ、表皮ブドウ球菌の皮膚付着を促進させる剤

Also Published As

Publication number Publication date
AU2006231248A2 (en) 2006-10-12
WO2006106220B1 (fr) 2007-02-08
US20100331276A1 (en) 2010-12-30
JP5107229B2 (ja) 2012-12-26
FR2883750A1 (fr) 2006-10-06
WO2006106220A3 (fr) 2007-01-04
WO2006106220A2 (fr) 2006-10-12
AU2006231248A1 (en) 2006-10-12
US20110212908A1 (en) 2011-09-01
AU2006231248B2 (en) 2012-08-02
JP2008534659A (ja) 2008-08-28
EP1868618A2 (fr) 2007-12-26
FR2883750B1 (fr) 2009-07-31
US20080200427A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
BRPI0813237B8 (pt) composto, método para preparar o composto, medicamento, e, uso do composto
CL2008003712A1 (es) Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion.
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
MX2010002247A (es) Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel.
CL2010001530A1 (es) Compuestos derivados de tiadiazoliloxifenilamidinas; su procedimiento de preparacion; agentes para combatir microorganismos indeseados que comprende a dichos compuestos; uso; procedimiento para combatir microorganismos indeseados; y compuestos intermediarios.
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
BRPI0712171A8 (pt) Método para formatar um gráfico e sistema para modificar um gráfico
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
CL2011002835A1 (es) Compuestos derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para tratar dolores agudos o cronicos de tipos neurogeno, asociados a enfermedades inflamatorias, entre otros.
BRPI0907663A2 (pt) ''composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições.
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
AR064149A1 (es) Sal fumarato de (alfa s , beta r)-6 bromo- alfa-[ 2(dimetilamino ) etil)-2- metoxi - alfa-1-naftalenil- beta- fenil-3- quinolinaetanol
GT201000037A (es) Depsipéptidos cíclicos
CL2007003232A1 (es) Compuestos derivados de 5-hidroximetil oxazolidin-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar y prevenir infecciones bacterianas.
DOP2011000285A (es) 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
CL2006001266A1 (es) Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas.
BRPI0814931A2 (pt) Composto com atividade contra hcv, sua composição e seu uso
AR060195A1 (es) Agentes, composiciones y metodos para aclarar la piel
CL2013001482A1 (es) Compuestos derivados de 3-metil-7-oxo-4-tia-1-aza-biciclo[3.2.0]heptano para utilizarse en la inhibicion de beta-lactamasas producidas por bacterias y restaurar/potenciar la actividad de antibioticos; y composicion farmaceutica que los comprende.
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
GT200600520A (es) Agentes antibacterianos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2508 DE 29-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.